- Home
- SYTA vs TOVX Comparison
SYTA vs TOVX Comparison
Compare SYTA & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYTA
- TOVX
- Stock Information
- Founded
- SYTA N/A
- TOVX 2001
- Country
- SYTA Canada
- TOVX United States
- Employees
- SYTA N/A
- TOVX N/A
- Industry
- SYTA Telecommunications Equipment
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- SYTA Telecommunications
- TOVX Health Care
- Exchange
- SYTA Nasdaq
- TOVX Nasdaq
- Market Cap
- SYTA 3.1M
- TOVX 3.6M
- IPO Year
- SYTA 2020
- TOVX 2006
- Fundamental
- Price
- SYTA $1.61
- TOVX $0.49
- Analyst Decision
- SYTA
- TOVX Hold
- Analyst Count
- SYTA 0
- TOVX 1
- Target Price
- SYTA N/A
- TOVX N/A
- AVG Volume (30 Days)
- SYTA 325.0K
- TOVX 2.4M
- Earning Date
- SYTA 05-19-2025
- TOVX 05-20-2025
- Dividend Yield
- SYTA N/A
- TOVX N/A
- EPS Growth
- SYTA N/A
- TOVX N/A
- EPS
- SYTA N/A
- TOVX N/A
- Revenue
- SYTA $11,629,572.00
- TOVX N/A
- Revenue This Year
- SYTA $14.02
- TOVX N/A
- Revenue Next Year
- SYTA N/A
- TOVX N/A
- P/E Ratio
- SYTA N/A
- TOVX N/A
- Revenue Growth
- SYTA 41.25
- TOVX N/A
- 52 Week Low
- SYTA $1.00
- TOVX $0.74
- 52 Week High
- SYTA $885.60
- TOVX $12.25
- Technical
- Relative Strength Index (RSI)
- SYTA 60.98
- TOVX 23.01
- Support Level
- SYTA $0.93
- TOVX $1.32
- Resistance Level
- SYTA $1.11
- TOVX $1.45
- Average True Range (ATR)
- SYTA 0.14
- TOVX 0.14
- MACD
- SYTA 0.08
- TOVX -0.09
- Stochastic Oscillator
- SYTA 84.06
- TOVX 0.86
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.